|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Novel association of smaller anterior chamber width with angle closure in Singaporeans显示文摘 | NONGPIUR ME SAKATA LM FRIEDMAN DS HE M CHAN YH LAVANYA R | 2010 | Oph- thalmology2010，117，10： | 1 |
| 2 | Association of narrow angles with ante- rior chamber area and volume measured with anterior seg- ment optical coherence tomography显示文摘 | WU RY NONGPIUR ME HE MG SAKATA LM FRIEDMAN DS CHAN YH | 2011 | Arch Ophthalmol2011，129，5： | 1 |
| 3 | Nanocrystal targeting in vivo显示文摘 | Akerman ME Chan WC Laakkonen P | 2002 | Proc Natl Acad Sci USA2002，99，12： | 1 |
| 4 | Phase 2 safety and activity trial of two dose levels of CCI-779 in women with previously treated locally advanced or metastatic cancer-Interim analysis显示文摘 | Chan S Johnston SR Scheulen ME | 2002 | Breast Cancer Research and Treatment2002，76，1： | 1 |
| 5 | Radiation-induced brain injury:A review显示文摘 | Greene-Schloesser D Robbins ME Peiffer AM Shaw EG Wheeler KT Chan MD | | 0，，： | 1 |
| 6 | Nanocrystal targeting in vivo显示文摘 | Akerman ME Chan WC Laakkonen P | 2002 | Proc Natl Acad Sci USA2002，99，12： | 1 |
| 7 | The 'ART' of thromboembolism: a review of assisted reproductive technology and thromboembolic cornplica?tions显示文摘 | Chan WS Dixon ME | 2008 | Thromb Res2008，121，6： | 1 |
| 8 | Mutations of the epidermal growthfactor receptor in non-small cell lung cancer search and destroy 显示文摘 | Chan SK Gullick WJ Hill ME | 2006 | Eur J Cancer2006，42，1： | 1 |
| 9 | Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease显示文摘 | Moorhead JF Chan MK Nahas ME | 1982 | Lancet1982，1，8311： | 1 |
| 10 | Imaging evaluation of lower extremity infrainguinal disease: role of the noninvasive vascular laboratory, computed tomography angiography, and magnetic resonance angiography显示文摘 | Chan D Anderson ME Dolmatch BL | 2010 | Tech Vase Interv Radiol2010，13，： | 1 |
| 11 | Mutations of the epidermal growth factor receptor in non-small cell lung cancer: seraph and destroy 显示文摘 | Chan SK Gullick WJ Hill ME | 2006 | Eur J Cancer2006，42，1： | 1 |
| 12 | Phase II study of temsirolimus ( CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or meta- static breast cancer 显示文摘 | Chan S Scheulen ME Johnston S | 2005 | J Clin Oncol2005，23，23： | 1 |
| 13 | An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease显示文摘Background:With the rising global prevalence of fatty liver disease related to metabolic dysfunction,the association of this common liver condition with chronic kidney disease(CKD)has become increasingly evident.In 2020,the more inclusive term metabolic dysfunction-associated fatty liver disease(MAFLD)was proposed to replace the term non-alcoholic fatty liver disease(NAFLD).The observed association between MAFLD and CKD and our understanding that CKD can be a consequence of underlying metabolic dysfunction support the notion that individuals with MAFLD are at higher risk of having and developing CKD compared with those without MAFLD.However,to date,there is no appropriate guidance on CKD in individuals with MAFLD.Furthermore,there has been little attention paid to the link between MAFLD and CKD in the Nephrology community.Methods and Results:Using a Delphi-based approach,a multidisciplinary panel of 50 international experts from 26 countries reached a consensus on some of the open research questions regarding the link between MAFLD and CKD.Conclusions:This Delphi-based consensus statement provided guidance on the epidemiology,mechanisms,management and treatment of MAFLD and CKD,as well as the relationship between the severity of MAFLD and risk of CKD,which establish a framework for the early prevention and management of these two common and interconnected diseases. | Dan-Qin Sun Giovanni Targher Christopher D.Byrne David C.Wheeler Vincent Wai-Sun Wong Jian-Gao Fan Herbert Tilg Wei-Jie Yuan Christoph Wanner Xin Gao Michelle T.Long Mehmet Kanbay Mindie H.Nguyen Sankar D.Navaneethan Yusuf Yilmaz Yuli Huang Rino A.Gani Pierluigi Marzuillo Jérôme Boursier Huijie Zhang Chan-Young Jung Jin Chai Luca Valenti George Papatheodoridis Giovanni Musso Yu-Jun Wong Mohamed El-Kassas Nahum Méndez-Sánchez Silvia Sookoian Michael Pavlides Ajay Duseja Adriaan G.Holleboom Junping Shi Wah-Kheong Chan Yasser Fouad Junwei Yang Sombat Treeprasertsuk Helena Cortez-Pinto Masahide Hamaguchi Manuel Romero-Gomez Mamun Al Mahtab Ponsiano Ocama Atsushi Nakajima Chunsun Dai Mohammed Eslam Lai Wei Jacob George Ming-Hua Zheng | 2023 | Hepatobiliary Surgery and Nutrition2023，12，3： | 1 |
| 14 | Mutations of the epidermal growth factor receptor in non-small cell lung cancer search and destroy 显示文摘 | Chan SK Gullick WJ Hill ME | 2006 | Eur J Cancer2006，42，1： | 1 |
| 15 | Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant silwet L-720 显示文摘 | Bowen RA Chan Y Ruddel ME | 2005 | Clin Chem2005，51，10： | 1 |
| 16 | The BH3 domain is required for caspase-independent cell death inducted by Bax anddi gomycin显示文摘 | Fitch ME Chan g CM Parslow TG | 2000 | Cell Death Differ2000，7，： | 1 |
| 17 | Prospective randomisedstudy of intra articular fractures of the distal radius:comparisonbetween external fixation and plate fixation显示文摘 | Xu GG Chan SP Puhaindran ME | 2009 | Ann Acad MedSingapore2009，38，7： | 1 |
| 18 | Phase Ⅱ study of temsirolimus (CCI-779) ,a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer 显示文摘 | Chan S Seheulen ME Johnston S | 2005 | J Clin Oncol2005，23，23： | 1 |
| 19 | The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosis显示文摘 | Chan ME Uzer G Rubin CT | 2013 | Curr Osteoporos Rep2013，11，： | 1 |
| 20 | Spontaneous pneumothorax out- come study ( SPOT phase I) : a 2-year review 显示文摘 | Ong ME Chan YH Kee TY | 2004 | Eur J Emerg Med2004，11，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员